Month: December 2020

I have great fun & satisfaction mentoring @IU_Health residents interested in #…

[ad_1] I have great fun & satisfaction mentoring @IU_Health residents interested in #retina & #research. Congrats to these fantastic current & prior IU residents for this recent publication on a most-feared complication of #eye surgery:https://t.co/5juDSOKEov [ad_2] Source by Thomas Ciulla, MD, MBA Return to main 

RT @ThomasCiullaMD: Our study has generated much interest in #Luxturna #genether…

[ad_1] RT @ThomasCiullaMD: Our study has generated much interest in #Luxturna #genetherapy #healtheconomics: Cost-effectiveness of Voretigene Nepa… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.

RT @ThomasCiullaMD: Just published: Suprachoroidal DNA nanoparticle genetherapy …

[ad_1]
RT @ThomasCiullaMD: Just published: Suprachoroidal DNA nanoparticle genetherapy preclinical study: https://t.co/XSE6Pydjjm
Suprachoroidall…
[ad_2]

Source by Thomas Ciulla, MD, MBA

Return to main website.

RT @ThomasCiullaMD: Honored to be interviewed by Dr. Wykoff of Retina Synthesis,…

[ad_1] RT @ThomasCiullaMD: Honored to be interviewed by Dr. Wykoff of Retina Synthesis, on the journey through disruptive retina innovation in aca… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.

RT @pharminews: Arctic Vision obtains the first IND approval for the treatment o…

[ad_1] RT @pharminews: Arctic Vision obtains the first IND approval for the treatment of UME in China, Suprachoroidal space (SCS) injection potent… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.

Recently published on visual acuity and anatomic correlations, which has import…

[ad_1]
Recently published on visual acuity and anatomic correlations, https://t.co/JXmAVegloW which has important implications for clinical treatment and clinical trials…

#eyes #ophthalmology #retina #diabetes #diabeticretinopathy #uveitis #clinicalresearch https://t.co/CEIkf2ASEd
[ad_2]

Source by Thomas Ciulla, MD, MBA

Return to main website.

Just published: Suprachoroidal DNA nanoparticle genetherapy preclinical study: …

[ad_1] Just published: Suprachoroidal DNA nanoparticle genetherapy preclinical study: https://t.co/XSE6Pydjjm Suprachoroidally Delivered DNA Nanoparticles Transfect Retina and Retinal Pigment Epithelium/Choroid in Rabbits | TVST | ARVO Journals #retina #suprachoroidal #GeneTherapy https://t.co/ERRLCc7Jd2 [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.

Honored to be interviewed by Dr. Wykoff of Retina Synthesis, on the journey thro…

[ad_1] Honored to be interviewed by Dr. Wykoff of Retina Synthesis, on the journey through disruptive retina innovation in academia, clinical practice and industry… #retina #biotech #genetherapy https://t.co/LYP417LVx0 via @YouTube [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.

RT @OphthTimes: . @REGENXBIO announces dosing of first patient in phase II ALTIT…

[ad_1]
RT @OphthTimes: . @REGENXBIO announces dosing of first patient in phase II ALTITUDE™ trial of RGX-314 for the diabetic retinopathy treatmen…
[ad_2]

Source by Thomas Ciulla, MD, MBA

Return to main website.

For COVID-19, mRNA vaccines have sprinted to approval. Historically, #retina pla…

[ad_1] For COVID-19, mRNA vaccines have sprinted to approval. Historically, #retina played an important role in #RNA #therapy development, with the first approved ASO in 1998. We just published on potential RNA therapies for #AMD, #diabeticretinopathy & IRDs… https://t.co/S9TpaLYBsg [ad_2] Source by Thomas Ciulla, MD,